A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis
Clinical trial NCT01162421 · COMPLETED
Trial details
- NCT number
- NCT01162421
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2015-07-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.